TrialInvestigational new drugs2024

Exposure-response relationships of venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory t(11;14) multiple myeloma patients.

Mohamed Ali Badawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.